Clinical N0 center of lymph nodes in papillary thyroid cancer treatment effect analysis.docVIP

 PAGE \* MERGEFORMAT 11 Clinical N0 center of lymph nodes in papillary thyroid cancer treatment effect analysis [Abstract] Objective: To investigate the central area of papillary thyroid carcinoma and neck lymph nodes and principles of treatment. Methods: Retrospective analysis of Jiangsu Cancer Hospital from 1998 to 2007 112 patients treated in clinical N0 patients with papillary thyroid carcinoma of the clinical data. Cure the original foci at the same time, analysis of the central area after lymph node dissection and cervical lymph node metastasis. Results: The overall cumulative survival rates were 5,10 years 100% and 98% of total regional recurrence rate was 4.46% and 8.93%. clinically N0 of papillary thyroid carcinoma lymph nodes removed, 65 cases, including 22 cases of lymph node-positive, simple gland resection and lobectomy + District gland lymph nodes in the surgical excision of two follow-up The incidence of cervical lymph node was no significant difference. Conclusion: The clinical N0 5,10 of papillary thyroid cancer no difference in survival rates, the primary tumor and the tumor without capsule multiple lesions of the central area of #8203;#8203;lymph node metastasis had significant effects. higher rate of lymph node metastasis area, should also complete the ipsilateral gland resection + area lymph node dissection, can reduce the incidence of cervical lymph node metastasis. [Keywords:] papillary thyroid cancer; the central area of lymph nodes; surgery [Abstract] Objective: To search the pattern of cervical lymph nod metastases from papillary carcinoma of the thyroid and to search an optional management for patients with thyroid papillary carcinoma. Methods: A retrospective review was conducted in 112 cases of papillary carcinoma of the thyroid in our hospital from 1998 to 2007. Results: The overall 5, 10 year accumulative survival rates were 100% and 98%, respectively. The 5, 10 year accumulative cervical recurrence rates were 4.46% a